Trial intelligence / Profile preview

IMPACT-DM: Intensified multifactorial intervention in coronary artery disease with type 2 diabetes

jRCTs031200359Active, not recruiting

Sponsor
Japan Society for the Promotion of Science
Start
Nov 2021
Countries
1
01

Overview

Randomised, open-label trial in coronary arteriosclerosis, type 2 diabetes mellitus (T2DM), hypertension (HTN) and 1 more (2 arms), sponsored by Japan Society for the Promotion of Science. Primary endpoint: Absolute changes in percent plaque volumes in non-target coronary lesions. Started Nov 2021; status: active, not recruiting.

02

Conditions

coronary arteriosclerosistype 2 diabetes mellitus (T2DM)hypertension (HTN)lipid disorder

Beyond the preview

Go deeper on jRCTs031200359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031200359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call